Definitive Healthcare Corp. DH

FY2025 · ended Dec 31, 2025 · Revenue $241.52M, -4.2% YoY · Filed Feb 26, 2026

Definitive Healthcare Corp. (DH) files with the SEC under industry code 7372, Services-Prepackaged Software. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $241.5 million and a net loss of $138.9 million. Free cash flow was $37.1 million. As of Jun 30, 2026 it held $183.6 million in cash and investments and $167.1 million in total debt.

Revenue (TTM)
$232.70M
-5.0% vs year-ago TTM
Net income (TTM)
$-168.20M
+44.8% vs year-ago TTM
Operating cash flow (TTM)
$41.43M
-34.2% vs year-ago TTM
Free cash flow (TTM)
$28.56M
-30.8% vs year-ago TTM
EPS (TTM)
$-1.61
+40.4% vs year-ago TTM
Dividend per share
None
Shares outstanding
104.47M
-7.5% vs prior year
Net cash
$16.54M
as of Jun 30, 2026
Operating margin
-104.6%
FY 2026

Company profile

Industry
Services-Prepackaged Software (SIC 7372)
Listed as
DH (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Framingham, MA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1861795

Other Services-Prepackaged Software companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$241.5M
$252.2M
$251.4M
$222.7M
$166.2M
Operating income
-$224.3M
-$710.8M
-$329.8M
-$44.0M
-$27.3M
Net income
-$138.9M
-$413.1M
-$202.4M
-$7.2M
-$17.8M
Diluted EPS
-$1.30
-$3.54
-$1.79
-$0.07
—
Operating cash flow
$53.8M
$58.2M
$41.2M
$35.6M
$25.2M
Free cash flow
$37.1M
$45.9M
$38.2M
$27.3M
$18.5M
Total assets
$735.5M
$1.1B
$1.8B
$2.1B
$2.1B
Total liabilities
$356.5M
$482.2M
$626.7M
$640.7M
$617.8M
Stockholders' equity
$379.0M
$607.2M
$1.2B
$1.5B
$1.5B
Cash and investments
$180.9M
$290.2M
$308.1M
$331.9M
$387.5M
Total debt
$174.1M
$254.1M
$269.4M
$277.9M
$273.3M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Sep 9, 2026 Sep 9, 2026
8-K Current report
Other events
Sep 2, 2026 Sep 2, 2026
8-K Current report
Officer or director change
Sep 2, 2026 Aug 28, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Listing notice
Jun 24, 2026 Jun 18, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.